Jan Henrik ter Meulen, Chief Scientific Officer at Immune Design Corp. (IMDZ), sold 980 shares at $5.35 ($5K) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Scheduled sale ($5k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |